Since 1998, Intellipharmaceutics has been an innovator in the international pharmaceutical market. The Company’s patented Hypermatrix™ technology is a unique and validated multidimensional controlled-release drug delivery platform that can be applied to the development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics is developing a pipeline of both generic and new drugs across a range of therapeutic classes.
© 2009. IntelliPharmaceutics All Rights Reserved.
Powered By: Big Solutions.
Intellipharmaceutics International was listed on the NASDAQ and TSX on October 22, 2009 (NASDAQ: IPCI; TSX: I).
Powered By: Big Solutions.